Enzolytics, Inc. (OTCMKTS:ENZC) Short Interest Update

Enzolytics, Inc. (OTCMKTS:ENZC) was the recipient of a large growth in short interest in the month of March. As of March 31st, there was short interest totalling 110,100 shares, a growth of 6,016.7% from the March 15th total of 1,800 shares. Based on an average daily trading volume, of 2,816,500 shares, the days-to-cover ratio is presently 0.0 days.

Enzolytics Stock Up 16.7 %

ENZC stock opened at $0.00 on Tuesday. Enzolytics has a 1 year low of $0.00 and a 1 year high of $0.01.

Enzolytics Company Profile

Enzolytics Inc, a drug development company, focuses to the commercialization of its proprietary proteins for the treatment of debilitating infectious diseases. Its patented anti-HIV therapeutics and a proprietary methodology for producing human IgG1 monoclonal antibodies for treating infectious diseases with non-toxic passive immunotherapy.